Invasive Ductal Carcinoma of Female Breast

2

Review clinical trials related to Invasive Ductal Carcinoma of Female Breast. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Radiation After No Axillary Nodal Sampling

This is a single arm, pilot, prospective study to evaluate the safety of partial breast irradiation in women who undergo breast conserving surgery without sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND). Baseline demographic and clinical information will be collected. All patients will complete the Breast Cancer Treatment Outcome Scale (BCTOS-13) questionnaire and the Functional Assessment of Chronic Illness Therapy-Comprehensive Score for financial Toxicity at baseline and at 2 years. All patients are required to have an axillary ultrasound prior to radiation start if this was not obtained pre-operatively.

Participants needed: 105
Trial details
Age: 40+Biological sex: FemaleType: InterventionalSponsor: NYU Langone HealthUpdated: Jul 23, 2026Locations: 1
Eligibility criteria

Individuals assigned Female at birth, age 40 and older [+8]

Male [+5]

Status: Recruiting

Accelerated Partial Breast Irradiation (APBI) Using Stereotactic Body Radiation Therapy (SBRT)

This is a multi-institutional, prospective, observational registry investigating the safety and efficacy of Accelerated Partial Breast Irradiation (APBI) using a Stereotactic Body Radiation Therapy (SBRT) delivery technique that incorporates real-time image guidance, noncoplanar fields, and respiratory tracking. The study will accrue 200 patients who will be treated to a dose of 30 Gy over the course of 5 fractions. These subjects will then have a follow up time of 5 years

Participants needed: 200
Trial details
Age: 50-100Biological sex: FemaleType: ObservationalSponsor: RPCR, Inc.Updated: Aug 5, 2022Locations: 2Duration: 5 Years
Eligibility criteria

Women 50 years or older [+10]

Lobular histology [+16]